Physician

James E Bell, MD

According to 2025 Medicare claims, James Bell, MD (NPI: 1376860668) practices ophthalmology in the Madison, WI market, with the plurality of this provider's patient population coming from Dane, WI. This provider's primary affiliated billing organization is DEAN HEALTH SYSTEMS, INC (NPI: 1053358846; TIN: 391128616) and primary practice location at 53715-1248. Bell is affiliated with the SSM WI ACO LLC (ACO ID: A5124), participating under the MSSP model.

Bell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 821 traditional Medicare patients, billed 21,552 HCPCS/CPT codes, and received $1,541,367 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 356 prescription claims across 118 beneficiaries totaling $17,887 in drug costs, led by Difluprednate (Difluprednate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,259 to $1,541,367. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $12,214 to $17,887. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$771K$1.5M2015 Medicare payment: $12,259 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $129,173 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $565,134 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $605,195 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $686,456 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $700,334 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,360,768 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,399,314 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,448,161 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,541,367 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201589146$12,259
2016220764$129,173
20175173,774$565,134
20186714,561$605,195
20196805,734$686,456
20206724,969$700,334
20218187,068$1,360,768
20228127,504$1,399,314
202378013,300$1,448,161
202482121,552$1,541,367

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$29K2015 Drug cost: $12,214 (USD; Tot_Drug_Cst)2016 Drug cost: $10,730 (USD; Tot_Drug_Cst)2017 Drug cost: $17,694 (USD; Tot_Drug_Cst)2018 Drug cost: $20,959 (USD; Tot_Drug_Cst)2019 Drug cost: $28,592 (USD; Tot_Drug_Cst)2020 Drug cost: $25,309 (USD; Tot_Drug_Cst)2021 Drug cost: $27,160 (USD; Tot_Drug_Cst)2022 Drug cost: $29,278 (USD; Tot_Drug_Cst)2023 Drug cost: $21,557 (USD; Tot_Drug_Cst)2024 Drug cost: $17,887 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201572200$12,214
201668155$10,730
201779312$17,694
201883306$20,959
201992392$28,592
202081285$25,309
202183313$27,160
202290346$29,278
2023100405$21,557
2024118356$17,887

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1401,086$657
67028Injection of drug into eye3301,144$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more628996$59
J9035Injection, bevacizumab, 10 mg182522$55
92134Imaging of retina7551,865$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate531,364$6,926
Prednisolone AcetatePrednisolone Acetate1204,040$3,661
Bromfenac SodiumBromfenac Sodium21535$2,411
Ketorolac TromethamineKetorolac Tromethamine562,092$749
OfloxacinOfloxacin551,254$488

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for James E. Bell, MD?

Tedicare shows public-source Medicare data for James E. Bell, MD (NPI 1376860668), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James E. Bell, MD have ACO affiliation data?

James E. Bell, MD is shown with ACO affiliation data for SSM WI ACO LLC (MSSP, ACO ID A5124).

What billing organization is linked to James E. Bell, MD?

James E. Bell, MD is linked to DEAN HEALTH SYSTEMS, INC (billing NPI 1053358846) in the available physician profile data.

Does James E. Bell, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.